Compare ALEMBIC with Suven Life Sciences - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs SUVEN LIFE SCIENCES - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC SUVEN LIFE SCIENCES ALEMBIC/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 59.5 -79.8 - View Chart
P/BV x 5.1 1.3 409.5% View Chart
Dividend Yield % 0.2 1.8 10.8%  

Financials

 ALEMBIC   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    ALEMBIC
Mar-18
SUVEN LIFE SCIENCES
Mar-19
ALEMBIC/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs72338 21.3%   
Low Rs34169 20.0%   
Sales per share (Unadj.) Rs4.752.1 9.0%  
Earnings per share (Unadj.) Rs6.16.8 89.4%  
Cash flow per share (Unadj.) Rs6.28.6 72.9%  
Dividends per share (Unadj.) Rs0.201.50 13.3%  
Dividend yield (eoy) %0.40.6 63.8%  
Book value per share (Unadj.) Rs40.765.3 62.3%  
Shares outstanding (eoy) m267.03127.28 209.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.34.9 231.6%   
Avg P/E ratio x8.737.1 23.4%  
P/CF ratio (eoy) x8.529.6 28.7%  
Price / Book Value ratio x1.33.9 33.5%  
Dividend payout %3.322.0 14.9%   
Avg Mkt Cap Rs m14,13932,272 43.8%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m207661 31.4%   
Avg. sales/employee Rs ThNM6,132.2-  
Avg. wages/employee Rs ThNM611.1-  
Avg. net profit/employee Rs ThNM803.5-  
INCOME DATA
Net Sales Rs m1,2556,635 18.9%  
Other income Rs m370242 152.8%   
Total revenues Rs m1,6256,877 23.6%   
Gross profit Rs m1111,604 6.9%  
Depreciation Rs m38221 17.1%   
Interest Rs m238 4.5%   
Profit before tax Rs m4421,587 27.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24718 3.3%   
Profit after tax Rs m1,630869 187.5%  
Gross profit margin %8.924.2 36.6%  
Effective tax rate %5.445.2 12.0%   
Net profit margin %129.813.1 990.9%  
BALANCE SHEET DATA
Current assets Rs m1,8676,232 30.0%   
Current liabilities Rs m5911,490 39.7%   
Net working cap to sales %101.671.5 142.2%  
Current ratio x3.24.2 75.5%  
Inventory Days Days9486 109.1%  
Debtors Days Days7483 89.0%  
Net fixed assets Rs m1,7914,043 44.3%   
Share capital Rs m534127 419.6%   
"Free" reserves Rs m10,3248,183 126.2%   
Net worth Rs m10,8588,310 130.7%   
Long term debt Rs m4118 231.5%   
Total assets Rs m11,59110,389 111.6%  
Interest coverage x260.943.1 605.2%   
Debt to equity ratio x00 177.1%  
Sales to assets ratio x0.10.6 17.0%   
Return on assets %14.18.7 161.2%  
Return on equity %15.010.5 143.5%  
Return on capital %15.219.5 77.8%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m195,622 0.3%   
Fx outflow Rs m2641,799 14.7%   
Net fx Rs m-2443,822 -6.4%   
CASH FLOW
From Operations Rs m236356 66.3%  
From Investments Rs m-224-279 80.4%  
From Financial Activity Rs m-27-225 11.8%  
Net Cashflow Rs m-15-148 10.0%  

Share Holding

Indian Promoters % 64.0 63.4 100.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.0 -  
FIIs % 9.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 36.5 71.5%  
Shareholders   54,701 37,287 146.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   SUN PHARMA  PROCTER & GAMBLE HEALTH  NOVARTIS  J.B.CHEMICALS  ORCHID PHARMA  

Compare ALEMBIC With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

A Time Correction in the Nifty(Momentum Moves)

The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading?(Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


Mar 5, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS